Next Article in Journal
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials
Next Article in Special Issue
Navigating the Road to Immunization Equity: Systematic Review of Challenges in Introducing New Vaccines into Sub-Saharan Africa’s Health Systems
Previous Article in Journal
A Recombinant Mosaic HAs Influenza Vaccine Elicits Broad-Spectrum Immune Response and Protection of Influenza a Viruses
Previous Article in Special Issue
COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia
 
 
Article

Article Versions Notes

Vaccines 2024, 12(9), 1009; https://doi.org/10.3390/vaccines12091009
Action Date Notes Link
article xml file uploaded 3 September 2024 05:38 CEST Original file -
article xml uploaded. 3 September 2024 05:38 CEST Update https://www.mdpi.com/2076-393X/12/9/1009/xml
article pdf uploaded. 3 September 2024 05:38 CEST Version of Record https://www.mdpi.com/2076-393X/12/9/1009/pdf
article supplementary file uploaded. 3 September 2024 05:38 CEST - https://www.mdpi.com/2076-393X/12/9/1009#supplementary
article html file updated 3 September 2024 05:41 CEST Original file https://www.mdpi.com/2076-393X/12/9/1009/html
Back to TopTop